Cost-effectiveness of adding FDG-PET or CT to the diagnostic work-up of patients with stage III melanoma.

Cost-effectiveness of adding FDG-PET or CT to the diagnostic work-up of patients with stage III melanoma.

Item
http://www.wikidata.org/entity/Q53134770
Long-term follow-up for melanoma patients: is there any evidence of a benefit?FDG PET/CT in cancer: comparison of actual use with literature-based recommendations.Cost-Effectiveness of Drug Treatments for Advanced Melanoma: A Systematic Literature Review.The Melanoma MAICare Framework: A Microsimulation Model for the Assessment of Individualized Cancer Care.Impact of Completion Lymph Node Dissection on Patients with Positive Sentinel Lymph Node Biopsy in Melanoma.Clinical impact of (18)F-FDG PET-CT in recurrent stage III/IV melanoma: a tertiary centre Specialist Skin Cancer Multidisciplinary Team (SSMDT) experience.Successful treatment of triple primary tumor.Prediction of positron emission tomography/computed tomography (PET/CT) positivity in patients with high-risk primary melanoma.Cost-effectiveness of Fluorine-18-Fluorodeoxyglucose positron emission tomography in tumours other than lung cancer: A systematic review.Whole body PET/CT in the follow-up of asymptomatic patients with stage IIB-IIIB cutaneous melanoma.Gastric and Rectal Metastases from Malignant Melanoma Presenting with Hypochromic Anemia and Treated with Immunotherapy.Outcome of clinical stage III melanoma patients with FDG-PET and whole-body CT added to the diagnostic workup.Patients undergoing lymphadenectomy for stage III melanomas of known or unknown primary site do not differ in outcome.Cost-effectiveness analysis of staging strategies in patients with regionally metastatic melanoma.[Whole-body staging of malignant melanoma: advantages, limitations and current importance of PET-CT, whole-body MRI and PET-MRI].
P2860

Cost-effectiveness of adding FDG-PET or CT to the diagnostic work-up of patients with stage III melanoma.

Item
http://www.wikidata.org/entity/Q53134770
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh-hant
name
Cost-effectiveness of adding F ...... ients with stage III melanoma.
@en
Cost-effectiveness of adding F ...... ients with stage III melanoma.
@nl
type
label
Cost-effectiveness of adding F ...... ients with stage III melanoma.
@en
Cost-effectiveness of adding F ...... ients with stage III melanoma.
@nl
prefLabel
Cost-effectiveness of adding F ...... ients with stage III melanoma.
@en
Cost-effectiveness of adding F ...... ients with stage III melanoma.
@nl
P1433
P1476
P2093
P304
P31
P356
P407
P433
P478
P50
P577
P698
P356
P1433
P1476
Cost-effectiveness of adding F ...... ients with stage III melanoma.
@en
P2093
P304
P31
P356
10.1097/SLA.0B013E31824A5742
P407
P433
P478
P50
P577
P698